As a result of serious concerns about the side effects of Avandia, which include an increased risk of heart attacks, congestive heart failure and other serious injuries, the American Diabetes Association and the European Association for the Study of Diabetes have dropped the drug from their consensus statement on type 2 diabetes treatments, unanimously advising against use of the drug. Continued

